Primary Site >> Stomach Cancer

Gene >> CD55

  • 1997
  • 1999
  • 2000
  • 2001
  • 2002
  • 2005
  • 2013
  • 2014
  • 2016
Ref: Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
PMID: 9121154
Ref: Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for antibody SC-1-induced apoptosis.
PMID: 10537313
Ref: [Adjuvant immunotherapy of stomach carcinoma with antibody-induced apoptosis].
PMID: 10929645
Ref: Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis.
PMID: 11706063
Ref: Expression of complement regulating factors in gastric cancer cells.
PMID: 12032231
Ref: Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
PMID: 16130195
Ref: Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
PMID: 16166423
Ref: The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas.
PMID: 16273233
Ref: Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab.
PMID: 23474221
Ref: Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.
PMID: 23917586
Ref: Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1.
PMID: 24452482
Ref: CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent.
PMID: 26233326